Latest News About - complementary theraphy devices

 
Show/hide duplicate news articles.
Filter by countryfromabout
<<10<12345678910>>>10
 
Show/hide duplicate news articles.
<<10<12345678910>>>10

Tools

Load latest edition

Saturday, September 26, 2020

10:04:00 AM CEST

Subscribe
RSS | MAP

Language Selection

For any category/filter, users can choose:

  1. the language of the categorized news items (e.g. fr and de to display only those news items in French and German)
  2. the language of the user interface (e.g. it for Italian)

In Top Stories, the user can display the largest clusters of news items for one language only (e.g. en shows all clusters in English)

Country Selection

Users can choose:

  1. country mentioned in the news item (articles about a country)
  2. country in which the news item was published (articles from a country)

Languages Collapse menu...Expand menu...Open help...

Select your languages

ar
az
be
bg
bs
ca
cs
da
de
el
en
eo
es
et
fa
fi
fr
ga
gl
ha
he
hi
hr
hu
hy
id
is
it
ja
ka
km
ko
ku
ky
lb
lo
lt
lv
mk
ml
mn
ms
mt
ne
nl
no
pap
pl
ps
pt
ro
ru
se
si
sk
sl
so
sq
sr
sv
sw
ta
th
tr
uk
ur
vi
zh
all
Show additional languagesHide additional languages

Interface:

Quotes... Extracted quotes

Levi Garraway said: “We are excited to announce the approval of Rozlytrek in Europe for two indications, bringing patients with NTRK and ROS1 gene fusions a new effective treatment even when their cancer has spread to the brain,” External link

onkologiisverige Friday, August 7, 2020 6:08:00 PM CEST

Levi Garraway said: “We are excited to announce the approval of Rozlytrek in Europe for two indications, bringing patients with NTRK and ROS1 gene fusions a new effective treatment even when their cancer has spread to the brain,” External link

4-traders Monday, August 3, 2020 7:14:00 AM CEST

Michael McQueen said: "We're a specialized form of high flow nasal cannula, and we're actually a type of non-invasive ventilation," External link

fosters Friday, July 31, 2020 1:08:00 PM CEST

Michael McQueen said: "In the early stages of this pandemic, the physicians were sure that the patients would need a ventilator, and so they intubated them. They quickly learned that the patient outcomes were just horrific. There were 80 percent mortality reports and 88 percent mortality reports depending on which system," External link

fosters Friday, July 31, 2020 1:08:00 PM CEST

Michael McQueen said: "In an effort to keep from intubating they switched to the high-flow nasal cannula, and with our device in particular we've heard they have had spectacular results in preventing that intubation," External link

fosters Friday, July 31, 2020 1:08:00 PM CEST

Michael McQueen said: "what hooks up to our device and delivers high flow at high velocity. That’s the differentiator. We're able to precisely give exactly as much oxygen as the patient needs - not too much, not too little, and that's important," "Combine that with proning the patients, a little bit of mild sedation, the anticoagulants, the steroids, and the other things that the docs have learned and the outcomes have completely reversed; they're doing much better" External link

fosters Friday, July 31, 2020 1:08:00 PM CEST

Levi Garraway said: “Once approved, Rozlytrek could become Roche’s first tumour-agnostic therapy in Europe,” External link

4-traders Friday, May 29, 2020 12:04:00 PM CEST

Most associated names

Daily number of articles in this category

Trend data not available for this selection.